# Coffee Holding Co Inc: financial statements, quarterly

JVA · Nasdaq · CIK 1007019 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Oct 31

Pages: [Overview](/companies/jva.md) · [Financials](/companies/jva/financials.md) · [Filings](/companies/jva/filings.md) · [Insiders](/companies/jva/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/jva/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-10-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | Q4 FY2024 (2024-10-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | Q4 FY2025 (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [18.8 d](/filings/0001493152-25-004500.md) | [19.5](/filings/0001493152-25-011093.md) | [19.0](/filings/0001641172-25-014979.md) | [18.8](/filings/0001493152-25-013137.md) | [21.2 d](/filings/0001493152-26-004052.md) | [21.3](/filings/0001493152-26-010270.md) | [23.3](/filings/0001493152-26-028451.md) | [23.9](/filings/0001493152-26-042313.md) | [27.7 d](/filings/0001493152-26-004052.md) | [25.6](/filings/0001493152-26-042313.md) | [22.1](/filings/0001493152-26-028451.md) | [21.7](/filings/0001493152-26-042313.md) |
| Cost of revenue | $m | [15.4 d](/filings/0001493152-25-004500.md) | [16.1](/filings/0001493152-25-011093.md) | [15.3](/filings/0001641172-25-014979.md) | [14.9](/filings/0001493152-25-013137.md) | [16.3 d](/filings/0001493152-26-004052.md) | [15.6](/filings/0001493152-26-010270.md) | [19.6](/filings/0001493152-26-028451.md) | [21.7](/filings/0001493152-26-042313.md) | [23.4 d](/filings/0001493152-26-004052.md) | [19.4](/filings/0001493152-26-042313.md) | [18.6](/filings/0001493152-26-028451.md) | [16.3](/filings/0001493152-26-042313.md) |
| Gross profit | $m | [3.4 d](/filings/0001493152-25-004500.md) | [3.5](/filings/0001493152-25-011093.md) | [3.7](/filings/0001641172-25-014979.md) | [3.9](/filings/0001493152-25-013137.md) | [4.9 d](/filings/0001493152-26-004052.md) | [5.7](/filings/0001493152-26-010270.md) | [3.7](/filings/0001493152-26-028451.md) | [2.3](/filings/0001493152-26-042313.md) | [4.3 d](/filings/0001493152-26-004052.md) | [6.1](/filings/0001493152-26-042313.md) | [3.5](/filings/0001493152-26-028451.md) | [5.4](/filings/0001493152-26-042313.md) |
| Selling, general and administrative | $m | [3.0 d](/filings/0001493152-25-004500.md) | [2.7](/filings/0001493152-25-011093.md) | [3.6](/filings/0001641172-25-014979.md) | [3.0](/filings/0001493152-25-013137.md) | [3.1 d](/filings/0001493152-26-004052.md) | [3.9](/filings/0001493152-26-010270.md) | [2.6](/filings/0001493152-26-028451.md) | [3.2](/filings/0001493152-26-042313.md) | [3.4 d](/filings/0001493152-26-004052.md) | [3.5](/filings/0001493152-26-028451.md) | [2.9](/filings/0001493152-26-028451.md) | [2.9](/filings/0001493152-26-042313.md) |
| Operating income | $m | [0.3 d](/filings/0001493152-25-004500.md) | [0.6](/filings/0001493152-25-011093.md) | [(0.1)](/filings/0001641172-25-014979.md) | [0.7](/filings/0001493152-25-013137.md) | [1.7 d](/filings/0001493152-26-004052.md) | [1.6](/filings/0001493152-26-010270.md) | [0.9](/filings/0001493152-26-028451.md) | [(1.1)](/filings/0001493152-26-042313.md) | [0.8 d](/filings/0001493152-26-004052.md) | [2.4](/filings/0001493152-26-042313.md) | [0.3](/filings/0001493152-26-028451.md) | [2.3](/filings/0001493152-26-042313.md) |
| Interest expense | $m | [0.2 d](/filings/0001493152-24-005726.md) | [0.1](/filings/0001493152-24-010340.md) | [0.1](/filings/0001493152-24-024160.md) | [0.0](/filings/0001493152-25-013137.md) | [0.0 d](/filings/0001493152-26-004052.md) | [0.0](/filings/0001493152-26-010270.md) | [0.0](/filings/0001493152-26-028451.md) | [0.1](/filings/0001493152-26-042313.md) | [0.1 d](/filings/0001493152-26-004052.md) | [0.1](/filings/0001493152-26-010270.md) | [0.0](/filings/0001493152-26-028451.md) | [0.0](/filings/0001493152-26-042313.md) |
| Income tax | $m | [0.1 d](/filings/0001493152-25-004500.md) | [0.1](/filings/0001493152-25-011093.md) | [(0.1)](/filings/0001641172-25-014979.md) | [0.3](/filings/0001493152-25-013137.md) | [0.5 d](/filings/0001493152-26-004052.md) | [0.4](/filings/0001493152-26-010270.md) | [0.2](/filings/0001493152-26-028451.md) | [0.0](/filings/0001493152-26-042313.md) | [(0.1) d](/filings/0001493152-26-004052.md) | [0.7](/filings/0001493152-26-010270.md) | [0.0](/filings/0001493152-26-028451.md) | [0.3](/filings/0001493152-26-042313.md) |
| Net income | $m | [0.2 d](/filings/0001493152-25-004500.md) | [0.4](/filings/0001493152-25-013137.md) | [(0.0)](/filings/0001493152-25-013137.md) | [0.6](/filings/0001493152-25-013137.md) | [1.3 d](/filings/0001493152-26-004052.md) | [1.2](/filings/0001493152-26-042313.md) | [0.6](/filings/0001493152-26-042313.md) | [(1.2)](/filings/0001493152-26-042313.md) | [0.8 d](/filings/0001493152-26-004052.md) | [1.6](/filings/0001493152-26-042313.md) | [0.3](/filings/0001493152-26-042313.md) | [2.0](/filings/0001493152-26-042313.md) |
| Diluted EPS | $ per share | not reported | [0.06](/filings/0001493152-25-011093.md) | not reported | [0.11](/filings/0001493152-25-013137.md) | not reported | [0.20](/filings/0001493152-26-010270.md) | [0.11](/filings/0001493152-26-028451.md) | [(0.21)](/filings/0001493152-26-042313.md) | not reported | [0.29](/filings/0001493152-26-010270.md) | [0.05](/filings/0001493152-26-028451.md) | [0.35](/filings/0001493152-26-042313.md) |
| Basic EPS | $ per share | not reported | [0.06](/filings/0001493152-25-011093.md) | not reported | [0.11](/filings/0001493152-25-013137.md) | not reported | [0.20](/filings/0001493152-26-010270.md) | [0.11](/filings/0001493152-26-028451.md) | [(0.21)](/filings/0001493152-26-042313.md) | not reported | [0.29](/filings/0001493152-26-010270.md) | [0.05](/filings/0001493152-26-028451.md) | [0.35](/filings/0001493152-26-042313.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-10-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | FY2024 (2024-10-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | FY2025 (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.7](/filings/0001493152-25-004500.md) | [2.4](/filings/0001493152-24-010340.md) | [2.4](/filings/0001493152-24-024160.md) | [3.1](/filings/0001493152-24-036225.md) | [1.4](/filings/0001493152-26-004052.md) | [2.4](/filings/0001493152-25-011093.md) | [1.8](/filings/0001641172-25-014979.md) | [1.0](/filings/0001493152-25-013137.md) | [0.7](/filings/0001493152-26-042313.md) | [2.7](/filings/0001493152-26-010270.md) | [2.3](/filings/0001493152-26-028451.md) | [2.9](/filings/0001493152-26-042313.md) |
| Current assets | $m | [34.0](/filings/0001493152-25-004500.md) | [29.6](/filings/0001493152-24-010340.md) | [27.0](/filings/0001493152-24-024160.md) | [26.8](/filings/0001493152-24-036225.md) | [28.4](/filings/0001493152-26-004052.md) | [31.5](/filings/0001493152-25-011093.md) | [32.3](/filings/0001641172-25-014979.md) | [38.0](/filings/0001493152-25-013137.md) | [35.4](/filings/0001493152-26-042313.md) | [33.5](/filings/0001493152-26-010270.md) | [32.0](/filings/0001493152-26-028451.md) | [33.7](/filings/0001493152-26-042313.md) |
| Total assets | $m | [42.2](/filings/0001493152-25-004500.md) | [37.6](/filings/0001493152-24-010340.md) | [34.9](/filings/0001493152-24-024160.md) | [33.1](/filings/0001493152-24-036225.md) | [34.0](/filings/0001493152-26-004052.md) | [38.9](/filings/0001493152-25-011093.md) | [39.7](/filings/0001641172-25-014979.md) | [45.9](/filings/0001493152-25-013137.md) | [42.0](/filings/0001493152-26-042313.md) | [41.2](/filings/0001493152-26-010270.md) | [39.1](/filings/0001493152-26-028451.md) | [40.2](/filings/0001493152-26-042313.md) |
| Current liabilities | $m | [15.4](/filings/0001493152-25-004500.md) | [10.7](/filings/0001493152-24-010340.md) | [8.2](/filings/0001493152-24-024160.md) | [7.3](/filings/0001493152-24-036225.md) | [6.8](/filings/0001493152-26-004052.md) | [9.1](/filings/0001493152-25-011093.md) | [6.5](/filings/0001641172-25-014979.md) | [17.0](/filings/0001493152-25-013137.md) | [12.8](/filings/0001493152-26-042313.md) | [11.0](/filings/0001493152-26-010270.md) | [8.8](/filings/0001493152-26-028451.md) | [8.1](/filings/0001493152-26-042313.md) |
| Total liabilities | $m | [18.5](/filings/0001493152-25-004500.md) | [13.5](/filings/0001493152-24-010340.md) | [10.9](/filings/0001493152-24-024160.md) | [8.4](/filings/0001493152-24-036225.md) | [7.8](/filings/0001493152-26-004052.md) | [11.6](/filings/0001493152-25-011093.md) | [11.8](/filings/0001641172-25-014979.md) | [19.1](/filings/0001493152-25-013137.md) | [14.5](/filings/0001493152-26-042313.md) | [12.4](/filings/0001493152-26-010270.md) | [10.1](/filings/0001493152-26-028451.md) | [9.2](/filings/0001493152-26-042313.md) |
| Shareholders' equity | $m | [24.0](/filings/0001493152-25-004500.md) | [24.3](/filings/0001493152-24-010340.md) | [24.3](/filings/0001493152-24-024160.md) | [24.9](/filings/0001493152-24-036225.md) | [26.2](/filings/0001493152-26-042313.md) | [27.3](/filings/0001493152-26-042313.md) | [28.0](/filings/0001493152-26-042313.md) | [26.8](/filings/0001493152-26-042313.md) | [27.6](/filings/0001493152-26-042313.md) | [28.8](/filings/0001493152-26-042313.md) | [29.0](/filings/0001493152-26-042313.md) | [31.0](/filings/0001493152-26-042313.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-10-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | Q4 FY2024 (2024-10-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | Q4 FY2025 (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(147) d](/filings/0001493152-25-004500.md) | [4,595](/filings/0001493152-25-011093.md) | [(1,204) d](/filings/0001641172-25-014979.md) | [1,819 d](/filings/0001493152-25-013137.md) | [222 d](/filings/0001493152-26-004052.md) | [(402)](/filings/0001493152-26-010270.md) | [(1,154) d](/filings/0001493152-26-028451.md) | [(3,841) d](/filings/0001493152-26-042313.md) | [378 d](/filings/0001493152-26-004052.md) | [6,609](/filings/0001493152-26-010270.md) | [39.5 d](/filings/0001493152-26-028451.md) | [1,147 d](/filings/0001493152-26-042313.md) |
| Capital expenditure | $k | [136 d](/filings/0001493152-25-004500.md) | not reported | not reported | [46.6 d](/filings/0001493152-25-013137.md) | [36.3 d](/filings/0001493152-26-004052.md) | [17.9](/filings/0001493152-26-010270.md) | [15.0 d](/filings/0001493152-26-028451.md) | [46.3 d](/filings/0001493152-26-042313.md) | [112 d](/filings/0001493152-26-004052.md) | [33.3](/filings/0001493152-26-010270.md) | [(4.5) d](/filings/0001493152-26-028451.md) | [53.9 d](/filings/0001493152-26-042313.md) |
| Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001493152-26-042313.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2023-01-31) | Q2 FY2023 (2023-04-30) | Q3 FY2023 (2023-07-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [5,709](/filings/0001493152-24-010340.md) | [5,709](/filings/0001493152-24-024160.md) | [5,709](/filings/0001493152-24-036225.md) | [5,709](/filings/0001493152-25-011093.md) | [5,709](/filings/0001641172-25-014979.md) | [5,709](/filings/0001493152-25-013137.md) | [5,709](/filings/0001493152-26-010270.md) | [5,709](/filings/0001493152-26-028451.md) | [5,709](/filings/0001493152-26-042313.md) | [5,709](/filings/0001493152-26-010270.md) | [5,709](/filings/0001493152-26-028451.md) | [5,709](/filings/0001493152-26-042313.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,708,599 at 2026-09-11, from the cover of the [10-Q filed 2026-09-11](/filings/0001493152-26-042313.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.